99 related articles for article (PubMed ID: 3487336)
1. Impaired natural killing activity in patients with rheumatoid arthritis. Clinical characteristics and a study of defective mechanisms.
Fantini F; Valenti F; Mercuriali F; Marin F; Panajotopoulos N
Boll Ist Sieroter Milan; 1986; 65(1):40-6. PubMed ID: 3487336
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies.
Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W
Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
5. Regulation of natural killer cell activity by macrophages in the rheumatoid joint and peripheral blood.
Combe B; Pope R; Darnell B; Kincaid W; Talal N
J Immunol; 1984 Aug; 133(2):709-13. PubMed ID: 6429243
[TBL] [Abstract][Full Text] [Related]
6. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
Fox RI; Fong S; Sabharwal N; Carstens SA; Kung PC; Vaughan JH
J Immunol; 1982 Jan; 128(1):351-4. PubMed ID: 6976376
[TBL] [Abstract][Full Text] [Related]
7. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
8. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph.
Fox RI; Fong S; Tsoukas C; Vaughan JH
J Immunol; 1984 Jun; 132(6):2883-7. PubMed ID: 6609962
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
10. Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases.
Masera RG; Carignola R; Staurenghi AH; Sartori ML; Lazzero A; Griot G; Angeli A
Chronobiologia; 1994; 21(1-2):127-32. PubMed ID: 7924633
[TBL] [Abstract][Full Text] [Related]
11. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
13. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
14. Decreased natural killer cell activity in atopic eczema.
Hall TJ; Rycroft R; Brostoff J
Immunology; 1985 Oct; 56(2):337-44. PubMed ID: 3876984
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the natural killer-like lymphocytes in rheumatoid synovial fluid.
Goto M; Zvaifler NJ
J Immunol; 1985 Mar; 134(3):1483-6. PubMed ID: 3968425
[TBL] [Abstract][Full Text] [Related]
16. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
17. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
18. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis.
Masuda M; Morimoto T; De Haas M; Nishimura N; Nakamoto K; Okuda K; Komiyama Y; Ogawa R; Takahashi H
J Rheumatol; 2003 Sep; 30(9):1911-7. PubMed ID: 12966590
[TBL] [Abstract][Full Text] [Related]
19. Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients.
Thewissen M; Linsen L; Geusens P; Raus J; Stinissen P
Immunol Lett; 2005 Sep; 100(2):205-10. PubMed ID: 16154497
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
